Introduction to DYNAMIKA V.7 by Image Analysis Group
Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field.
Innovation Recognition and Impact
DYNAMIKA V.7 has been honored as an Award Category Winner for Innovation at the 2024 Pharmaceutical Technology Excellence Awards. This recognition underscores the platform's proprietary technology and its significant influence on driving change within the pharmaceutical research landscape.
Significance of DYNAMIKA V.7
Dr. Olga Kubassova, IAG's founder and President, highlighted the importance of this milestone, stating, "This milestone is another essential step as IAG continues to bring innovation to the medical imaging space." The comprehensive quality compliance it boasts positions IAG as a preferred partner for companies looking to enhance the safety and efficacy of their drug candidates through effective imaging biomarkers.
Features and Advantages of DYNAMIKA
DYNAMIKA provides intelligent workflows for medical imaging, focusing on data management and quality control. This platform ensures a streamlined process for assessing treatment efficacy and safety in clinical trials.
User-Friendly Experience
Among the many benefits, DYNAMIKA simplifies and automates imaging workflows through a user-friendly interface. It accelerates the radiological reading process, which reduces site burden while boosting site collaboration and participation.
Quality Compliance and Commitment
DYNAMIKA was developed with adherence to 21 CFR Part 11, which governs electronic records and signatures in the United States, as well as ISO 13485, an internationally recognized standard for quality management in medical device design and manufacture. This commitment to quality and compliance highlights IAG’s dedication to security and innovation in clinical research.
Support Across Trial Phases
Importantly, DYNAMIKA supports research across all phases, from Phase I to IV, for trials of varied sizes. This capability ensures that organizations can rely on its functionality for various projects, regardless of scope.
About Image Analysis Group (IAG)
Image Analysis Group is an esteemed imaging Clinical Research Organization (iCRO) that merges medical and operational expertise with cutting-edge technology. Serving the biotech and pharmaceutical sectors since 2007, IAG reliably supports imaging trials across numerous indications, enhancing the value of novel therapeutic assets through successful partnerships.
Contact Information
If you wish to learn more about DYNAMIKA V.7 or have any questions, you can reach IAG’s representative, Brittany Kearns, at 571-271-7211.
Frequently Asked Questions
What is DYNAMIKA V.7?
DYNAMIKA V.7 is a cloud-based platform developed by Image Analysis Group for managing and analyzing imaging data in clinical trials.
What certifications has DYNAMIKA V.7 achieved?
It has achieved SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification.
How does DYNAMIKA enhance clinical trials?
DYNAMIKA streamlines imaging workflows, improves radiological accuracy, and enables data interoperability to provide real-time insights.
What phases of clinical trials does DYNAMIKA support?
DYNAMIKA supports all phases of clinical trials, from Phase I through to Phase IV.
Who can be contacted for more information about IAG?
Brittany Kearns, the contact representative at IAG, can be reached at 571-271-7211 for any inquiries.
